EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Redox Chronobiology of Secondary Hyperparathyroidism in Chronic Kidney Disease: Exploring the Circadian–Melatonin–PTH Axis

Hsuan-Chu Hsu, Chia-Chao Wu iD, Kuo-Cheng Lu

Antioxidants · 24.09.2026 · 15 (10) · 1235

DOI: 10.3390/antiox15101235 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 24.09.2026. Verfasst von Hsuan-Chu Hsu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Yangming Branch, Taipei City Hospital, Taipei 111024, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Human Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novelty of this review lies in its falsifiable, time-resolved framework that integrates the parathyroid molecular clock with melatonin loss, compartment-specific redox failure, and bidirectional PTH–immune signalling rather than treating these mechanisms as parallel associations. Secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) is conventionally attributed to phosphate retention, calcitriol deficiency, hypocalcaemia, and fibroblast growth factor 23 (FGF23) resistance. We synthesise evidence linking mitochondrial reactive oxygen species (ROS), NADPH oxidase (NOX) activation and impaired nuclear factor erythroid 2-related factor 2 (NRF2)–Kelch-like ECH-associated protein 1 (KEAP1) signalling to uraemic toxins, inflammation, hyperphosphataemia and dialysis-related oxidant stress. Sustained ROS engage NF-κB, MAPK and endoplasmic reticulum stress pathways that drive parathyroid dysfunction, RANKL-dependent osteoclastogenesis, endothelial dysfunction and vascular smooth-muscle-cell calcification. Inflammation is treated as bidirectional: immune activation amplifies ROS and mineral-tissue injury, while sustained PTH may reciprocally modify monocyte/macrophage, neutrophil and lymphocyte function—an immunological arm that remains hypothesis-generating given sparse, uraemia-confounded evidence in CKD–SHPT. We convert this synthesis into four testable predictions: CKD-stage-specific uncoupling of 24-h PTH and melatonin profiles; redox-dependent loss of chief-cell mineral sensing; cell-specific immune effects of PTH at patient-relevant concentrations; and differential responses to timed versus conventional SHPT therapy. Melatonin may oppose redox and inflammatory injury through receptor-dependent and mitochondrial actions. Because physiological ROS are essential signalling mediators, we emphasise redox balance rather than maximal antioxidant capacity, distinguish human, animal and cellular evidence, and flag supraphysiological PTH, phosphate and melatonin exposures. The proposed axis is a mechanistic research framework, not a basis for routine melatonin, antioxidant or immune-directed therapy pending dedicated CKD outcome trials.

Schlagwörter

Stichwörter der Autor:innen

NADPH oxidaseNRF2–KEAP1RANKLchronic kidney diseasecircadian rhythmimmune dysfunctioninflammationmelatoninmitochondrial ROSoxidative stresssecondary hyperparathyroidismvascular calcification

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Yangming Branch, Taipei City Hospital, Taipei 111024, Taiwan.
  • Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, No. 155, Section 2, Linong St, Taipei 11221, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei 114202, Taiwan.
  • Department and Graduate Institute of Microbiology and Immunology, National Defense Medical University, Taipei 114201, Taiwan.
  • Division of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
  • Division of Nephrology, Department of Medicine, Fu-Jen Catholic University Hospital, New Taipei City 24352, Taiwan.

ORCID-Profile: Chia-Chao Wu

Förderung

  • Human Medical Research Foundation

Zitieren

APA

Hsu, H. C., Wu, C. C., & Lu, K. C. (2026). Redox Chronobiology of Secondary Hyperparathyroidism in Chronic Kidney Disease: Exploring the Circadian–Melatonin–PTH Axis. Antioxidants, 15(10), 1235. https://doi.org/10.3390/antiox15101235

Vancouver

Hsu HC, Wu CC, Lu KC. Redox Chronobiology of Secondary Hyperparathyroidism in Chronic Kidney Disease: Exploring the Circadian–Melatonin–PTH Axis. Antioxidants. 2026;15(10):1235. doi:10.3390/antiox15101235

BibTeX
@article{Hsu2026,
  author = {Hsu, Hsuan-Chu and Wu, Chia-Chao and Lu, Kuo-Cheng},
  title = {Redox Chronobiology of Secondary Hyperparathyroidism in Chronic Kidney Disease: Exploring the Circadian–Melatonin–PTH Axis},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {1235},
  doi = {10.3390/antiox15101235}
}
Kostenlos starten →